PubRank

R P Friedland

Author PubWeight™ 80.82‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Regional cerebral metabolic alterations in dementia of the Alzheimer type: positron emission tomography with [18F]fluorodeoxyglucose. J Comput Assist Tomogr 1983 1.77
2 Epidemiology, education, and the ecology of Alzheimer's disease. Neurology 1993 1.73
3 Longitudinal study of cerebral metabolic asymmetries and associated neuropsychological patterns in early dementia of the Alzheimer type. Arch Neurol 1990 1.62
4 Diffusion tensor imaging of normal-appearing white matter in mild cognitive impairment and early Alzheimer disease: preliminary evidence of axonal degeneration in the temporal lobe. AJNR Am J Neuroradiol 2007 1.57
5 Smoking and cognitive impairment: a population-based study. J Am Geriatr Soc 1996 1.56
6 Apolipoprotein E-epsilon4 alleles in cerebral amyloid angiopathy and cerebrovascular pathology associated with Alzheimer's disease. Am J Pathol 1996 1.54
7 Cerebral amyloid beta protein deposits and other Alzheimer lesions in non-demented elderly east Africans. Brain Pathol 1996 1.47
8 Abnormal connectivity of the visual pathways in human albinos demonstrated by susceptibility-sensitized MRI. Neurology 1994 1.44
9 Neuronal oxidative stress precedes amyloid-beta deposition in Down syndrome. J Neuropathol Exp Neurol 2000 1.31
10 Cerebrospinal fluid production is reduced in healthy aging. Neurology 1990 1.31
11 Pathological and positron emission tomographic correlations in Alzheimer's disease. Lancet 1985 1.29
12 A 1-year multicenter placebo-controlled study of acetyl-L-carnitine in patients with Alzheimer's disease. Neurology 1996 1.24
13 Prevalence of Alzheimer's type dementia in an elderly Arab population. Eur J Neurol 2001 1.23
14 Longitudinal study of the early neuropsychological and cerebral metabolic changes in dementia of the Alzheimer type. J Clin Exp Neuropsychol 1988 1.20
15 Heterogeneous anterior-posterior metabolic patterns in dementia of the Alzheimer type. Neurology 1988 1.18
16 Sex and electroencephalographic synchronization after photic stimulation predict signal changes in the visual cortex on functional MR images. AJNR Am J Neuroradiol 1998 1.14
17 Hypertension increases the probability of Alzheimer's disease and of mild cognitive impairment in an Arab community in northern Israel. Neuroepidemiology 2009 1.12
18 Nicotine inhibits amyloid formation by the beta-peptide. Biochemistry 1996 1.08
19 Differences in lateral hemispheric asymmetries of glucose utilization between early- and late-onset Alzheimer-type dementia. Am J Psychiatry 1985 1.07
20 Positron emission tomography with [18F]fluorodeoxyglucose differentiates normal pressure hydrocephalus from Alzheimer-type dementia. J Neurol Neurosurg Psychiatry 1985 1.07
21 Worker functions and traits associated with occupations and the development of AD. Neurology 2004 1.07
22 Neuroanatomical abnormalities in obsessive-compulsive disorder detected with quantitative X-ray computed tomography. Am J Psychiatry 1988 1.06
23 Alzheimer's disease: anterior-posterior and lateral hemispheric alterations in cortical glucose utilization. Neurosci Lett 1985 1.05
24 Retrieval from semantic memory in Alzheimer-type dementia. J Clin Exp Neuropsychol 1986 1.01
25 Longitudinal studies of regional cerebral metabolism in Alzheimer's disease. Neurology 1988 1.01
26 Cortical localization of human sustained attention: detection with functional MR using a visual vigilance paradigm. J Comput Assist Tomogr 1996 1.01
27 Hemi-inattention and hemisphere specialization: introduction and historical review. Adv Neurol 1977 0.98
28 The very high prevalence of AD in an Arab population is not explained by APOE epsilon4 allele frequency. Neurology 2000 0.97
29 Delirium in Alzheimer disease. Alzheimer Dis Assoc Disord 1997 0.97
30 Visuoconstructive performance and regional cerebral glucose metabolism in Alzheimer's disease. J Clin Exp Neuropsychol 1991 0.97
31 Cerebral metabolic and cognitive studies in dementia with frontal lobe behavioral features. J Psychiatr Res 1990 0.96
32 Vascular abnormalities: the insidious pathogenesis of Alzheimer's disease. Neurobiol Aging 2000 0.95
33 High-resolution PET studies in Alzheimer's disease. Neuropsychopharmacology 1991 0.94
34 Olfactory detection and identification performance are dissociated in early Alzheimer's disease. Neurology 1988 0.93
35 Effects of educational attainment on the clinical expression of Alzheimer's disease: results from a research registry. Am J Alzheimers Dis Other Demen 2001 0.92
36 Evaluation of risk factors for Alzheimer's disease in elderly east Africans. Brain Res Bull 1997 0.92
37 Serum albumin concentration and cognitive impairment. Curr Alzheimer Res 2010 0.90
38 Dementia and driving: an attempt at consensus. Alzheimer Dis Assoc Disord 1997 0.89
39 Neocortical metabolic abnormalities precede nonmemory cognitive impairments in early dementia of the Alzheimer type: longitudinal confirmation. J Neural Transm Suppl 1987 0.87
40 Behavioral symptomatology in dementia of the Alzheimer type. Alzheimer Dis Assoc Disord 1988 0.87
41 Plasma total homocysteine levels, dietary vitamin B6 and folate intake in AD and healthy aging. J Nutr Health Aging 2003 0.87
42 Apolipoprotein E polymorphism in elderly east Africans. East Afr Med J 1997 0.87
43 Video-game palsy: distal ulnar neuropathy in a video-game enthusiast. N Engl J Med 1984 0.86
44 PET quantification of specific binding of carbon-11-nicotine in human brain. J Nucl Med 1998 0.85
45 The Stroop color-word test: indicator of dementia severity. Int J Neurosci 1984 0.84
46 On the use of surrogate respondents for controls in a case-control study of Alzheimer's disease. J Am Geriatr Soc 2001 0.83
47 Diminished submandibular salivary flow in dementia of the Alzheimer type. J Gerontol 1990 0.83
48 Serum amyloid P is not present in amyloid beta deposits of a transgenic animal model. Neuroreport 1999 0.83
49 Regional cerebral glucose metabolism is normal in young adults with Down syndrome. J Cereb Blood Flow Metab 1990 0.82
50 Brain growth and cognitive improvement in children with human immunodeficiency virus-induced encephalopathy after 6 months of continuous infusion zidovudine therapy. J Acquir Immune Defic Syndr 1991 0.82
51 Autosomal dominant motor system degeneration in a black family. Ann Neurol 1983 0.82
52 Smoking and risk of Alzheimer's disease. MIRAGE Study Group. Lancet 1998 0.82
53 Plasticity in the aging brain. Reversibility of anatomic, metabolic, and cognitive deficits in normal-pressure hydrocephalus following shunt surgery. Arch Neurol 1990 0.81
54 Assessment of cerebral blood flow reserve using functional magnetic resonance imaging. J Magn Reson Imaging 1997 0.81
55 Cerebrospinal fluid monoamine markers are decreased in dementia of the Alzheimer type with extrapyramidal features. Neurology 1988 0.81
56 Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy: study of two American families with predominant dementia. J Neurol Sci 1997 0.81
57 Amyloid-beta protein angiopathies masquerading as Alzheimer's disease? Ann N Y Acad Sci 1997 0.81
58 Cerebrovascular muscle atrophy is a feature of Alzheimer's disease. Brain Res 1998 0.81
59 Saccadic intrusions in Alzheimer-type dementia. J Neurol 1983 0.80
60 Concurrence of Alzheimer's disease, Parkinson's disease, diffuse Lewy body disease, and amyotrophic lateral sclerosis. J Neurol Sci 1995 0.80
61 The complex picture test in dementia. Dement Geriatr Cogn Dis Extra 2012 0.80
62 Serial quantitative CT analysis of brain morphometrics in adult Down's syndrome at different ages. Neurology 1989 0.80
63 Processes of verbal memory failure in Alzheimer-type dementia. Brain Cogn 1985 0.80
64 Evolution of oculomotor and clinical findings in autopsy-proven Richardson syndrome. Neurology 2009 0.80
65 Bitemporal hypometabolism in Creutzfeldt-Jakob disease measured by positron emission tomography with [18F]-2-fluorodeoxyglucose. J Comput Assist Tomogr 1984 0.79
66 Evidence against the transmissibility of Alzheimer's disease. Neurology 1991 0.79
67 Olfactory detection and recognition in Alzheimer's disease. Lancet 1987 0.79
68 Quantitative comparison of cerebral glucose metabolic rates from two positron emission tomographs. J Nucl Med 1989 0.79
69 Development of a monoclonal antibody specific for beta/A4 amyloid in Alzheimer's disease brain for application to in vivo imaging of amyloid angiopathy. J Nucl Med 1992 0.78
70 Plasma homocysteine, vitamin B12 and folate in Alzheimer's patients and healthy Arabs in Israel. J Neurol Sci 2004 0.78
71 The diagnosis of Alzheimer-type dementia. A preliminary comparison of positron emission tomography and proton magnetic resonance. JAMA 1984 0.78
72 Digital and palmar dermatoglyphics in dementia of the Alzheimer type. Am J Med Genet 1988 0.78
73 Response of the hypothalamic-pituitary-adrenal axis to lumbar puncture induced stress. J Alzheimers Dis 2000 0.78
74 Concomitants of visual hallucinations in Alzheimer's disease. Neurology 1994 0.77
75 Labeled choline and phosphorylcholine: body distribution and brain autoradiography: concise communication. J Nucl Med 1983 0.77
76 Brain tumor evaluation using Rb-82 and positron emission tomography. J Nucl Med 1982 0.77
77 Atherosclerotic lesions are associated with increased immunoreactivity for inducible nitric oxide synthase and endothelin-1 in thoracic aortic intimal cells of hyperlipidemic Watanabe rabbits. Exp Mol Pathol 2001 0.77
78 Alpha-melanocyte-stimulating hormonelike immunoreactivity is increased in cerebrospinal fluid of patients with Parkinson's disease. Arch Neurol 1988 0.77
79 Cerebrospinal fluid neurochemistry in the myoclonic subtype of Alzheimer's disease. Ann Neurol 1988 0.76
80 Uses of biological markers. Alzheimer Dis Assoc Disord 1992 0.76
81 Quantitative X-ray computed tomography (CT) in dementia of the Alzheimer type (DAT). Can J Neurol Sci 1986 0.75
82 Increased expression of NOS and ET-1 immunoreactivity in human colorectal metastatic liver tumours is associated with selective depression of constitutive NOS immunoreactivity in vessel endothelium. J Submicrosc Cytol Pathol 2002 0.75
83 Managing Alzheimer's patients. Science 1998 0.75
84 Julius Hallervorden. Neurology 1993 0.75
85 Adrenal cortical carcinoma with Cushing's syndrome, organic psychosis, and aphasia in a seventy-one-year-old woman. Mt Sinai J Med 1978 0.75
86 Methodologic factors affecting PET measurements of cerebral glucose metabolism. J Nucl Med 1986 0.75
87 Absence of somatosensory evoked potentials in patients with anosognosia. Neurology 1977 0.75
88 Temporal patterns of uncoupling between oxidative metabolism and regional cerebral blood flow demonstrated by functional magnetic resonance imaging. Invest Radiol 1995 0.75
89 The effect of agonists and antagonists on the morphology of non-transformed human smooth muscle cell in vitro. J Submicrosc Cytol Pathol 2001 0.75
90 Decreased constitutive nitric oxide synthase, but increased inducible nitric oxide synthase and endothelin-1 immunoreactivity in aortic endothelial cells of donryu rats on a cholesterol-enriched diet. Anat Rec 2000 0.75
91 Hematocrit, viscosity and cerebral blood flow. Am Heart J 1979 0.75
92 Neuropsychological features of early and late-onset Alzheimer's disease. Arch Neurol 1987 0.75
93 Behavioral disorders associated with hemi-inattention. Adv Neurol 1977 0.75
94 Transmission of Creutzfeldt-Jakob disease. Lancet 1979 0.75
95 Duane's syndrome with giant aneurysm of the vertebral basilar arterial junction. J Clin Neuroophthalmol 1993 0.75
96 CSF alpha-MSH in dementia of the Alzheimer type. Neurology 1988 0.75